A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors.

Subjects

Subjects :

Adolescent
Chemotherapy, Adjuvant
Child, Preschool
Dose-Response Relationship, Drug
Drug Evaluation
Factor IX immunology
Factor VII economics
Factor VIII immunology
Factor VIIa
Hemophilia A complications
Hemophilia A immunology
Hemophilia B complications
Hemophilia B drug therapy
Hemophilia B immunology
Hemorrhage drug therapy
Humans
Isoantibodies blood
Recombinant Proteins economics
Factor VII administration & dosage
Hemophilia A drug therapy
Hemorrhage prevention & control
Recombinant Proteins administration & dosage

Details

Language :

English

ISSN :

1351-8216

Volume :

7

Issue :

5

Database :

MEDLINE

Journal :

Haemophilia : the official journal of the World Federation of Hemophilia

Publication Type :

Editorial & Opinion

Accession number :

11554948

Full Text :

https://doi.org/10.1046/j.1365-2516.2001.0537a.x